As of 2025-09-19, the Relative Valuation of Design Therapeutics Inc (DSGN) is (15.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.95 USD, the upside of Design Therapeutics Inc based on Relative Valuation is -352.5%.
The range of the Relative Valuation is (15.50) - (15.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 13.9x | 13.9x |
| Forward P/E multiples | 12.6x - 13.5x | 13.0x |
| Fair Price | (15.50) - (15.05) | (15.02) |
| Upside | -360.4% - -352.9% | -352.5% |
| Date | P/E |
| 2025-09-08 | -5.22 |
| 2025-09-05 | -5.79 |
| 2025-09-04 | -5.48 |
| 2025-09-03 | -5.35 |
| 2025-09-02 | -5.14 |
| 2025-08-29 | -4.96 |
| 2025-08-28 | -5.06 |
| 2025-08-27 | -4.75 |
| 2025-08-26 | -4.85 |
| 2025-08-25 | -4.66 |
| 2025-08-22 | -4.72 |
| 2025-08-21 | -4.62 |
| 2025-08-20 | -4.30 |
| 2025-08-19 | -4.64 |
| 2025-08-18 | -4.84 |
| 2025-08-15 | -4.78 |
| 2025-08-14 | -4.63 |
| 2025-08-13 | -4.86 |
| 2025-08-12 | -4.47 |
| 2025-08-11 | -4.32 |
| 2025-08-08 | -3.84 |
| 2025-08-07 | -3.56 |
| 2025-08-06 | -3.90 |
| 2025-08-05 | -3.64 |
| 2025-08-04 | -3.55 |
| 2025-08-01 | -3.43 |
| 2025-07-31 | -3.47 |
| 2025-07-30 | -3.61 |
| 2025-07-29 | -3.57 |
| 2025-07-28 | -3.62 |
| 2025-07-25 | -3.61 |
| 2025-07-24 | -3.62 |
| 2025-07-23 | -3.83 |
| 2025-07-22 | -3.81 |
| 2025-07-21 | -3.63 |
| 2025-07-18 | -3.57 |
| 2025-07-17 | -3.61 |
| 2025-07-16 | -3.72 |
| 2025-07-15 | -3.52 |
| 2025-07-14 | -3.59 |
| 2025-07-11 | -3.52 |
| 2025-07-10 | -3.62 |
| 2025-07-09 | -3.74 |
| 2025-07-08 | -3.27 |
| 2025-07-07 | -3.18 |
| 2025-07-03 | -3.38 |
| 2025-07-02 | -3.30 |
| 2025-07-01 | -3.16 |
| 2025-06-30 | -3.02 |
| 2025-06-27 | -3.20 |